Litcius/Paper detail

Status of biomarkers for the identification of stable or vulnerable plaques in atherosclerosis

Valter Lubrano, Silvana Balzan

2021Clinical Science19 citationsDOI

Abstract

Atherosclerosis is a systemic inflammation of the arteries characterized by atherosclerotic plaque due to the accumulation of lipids, inflammatory cells, apoptotic cells, calcium and extracellular matrix (ECM) proteins. Stable plaques present a chronic inflammatory infiltration, whereas vulnerable plaques present an 'active' inflammation involved in the thinning of the fibrous cap that predisposes to plaque rupture. Several complex biological cellular processes lead plaques to evolve from stable to vulnerable predisposing them to rupture and thrombosis. In this review, we analyze some emerging circulating biomarkers related to inflammation, ECM and lipid infiltration, angiogenesis, metalloproteinases and microRNA (miRNA), as possible diagnostic and prognostic indicators of plaque vulnerability.

Topics & Concepts

InflammationExtracellular matrixFibrous capMatrix metalloproteinaseInfiltration (HVAC)Vulnerable plaqueThrombosisAngiogenesisPathologyMedicineImmunologyBiologyCancer researchCell biologyInternal medicinePhysicsThermodynamicsAtherosclerosis and Cardiovascular DiseasesCell Adhesion Molecules ResearchProtease and Inhibitor Mechanisms
Status of biomarkers for the identification of stable or vulnerable plaques in atherosclerosis | Litcius